However, OSCC cells have developed different strategies to counteract immune recognition involving both intrinsic cancer related factors and extrinsic mechanisms, such as an immune suppressive TME and the downregulated expression of HLA-I APM surface antigen components recognized by tumor-specific T cells due to the reduced expression of HLA-I APM components [6]. This evidence concerns the gene ANPEP and neoplasm.